Sublingual Immunotherapy Reduces Symptoms of Asthma, Allergic Rhinoconjunctivitis
With the US Food and Drug Administration's recent approval of 2 sublingual immunotherapies for allergic rhinitis with or without conjunctivitis, US physicians no longer have to pursue the off-label use of these treatments.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.